Nantahala Capital Management, LLC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1472322 New Canaan, CT

Position in ACHV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,907,721

-$1,317,237 QoQ

Shares Held

648,885

0.0% QoQ

Ownership

0.632%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

of 81 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Nantahala Capital Management, LLC holds $574,927,961 across 52 Biotechnology names. ACHV ranks #46 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SLNO	Soleno Therapeutics Inc	1,744,124	$58,393,271
2	SVRA	Savara Inc	7,344,783	$40,102,515
3	TNGX	Tango Therapeutics, Inc.	1,250,452	$26,159,455
4	LBRX	Lb Pharmaceuticals Inc	1,052,894	$25,964,366
5	MLYS	Mineralys Therapeutics, Inc.	895,481	$24,258,580
6	ZVRA	Zevra Therapeutics, Inc.	2,521,936	$23,504,443
7	FULC	Fulcrum Therapeutics, Inc.	3,050,040	$23,393,806
8	ABEO	Abeona Therapeutics Inc.	5,013,052	$22,458,472

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,907,721	648,885	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,224,958	648,885	0.0%	Shares	Sole	2026-02-13
2025-09-30	$2,043,987	648,885	-27.8%	Shares	Sole	2025-11-14
2025-06-30	$2,031,480	898,885	0.0%	Shares	Sole	2025-08-14
2025-03-31	$2,400,022	898,885	+37.4%	Shares	Sole	2025-05-15
2024-12-31	$2,302,080	654,000	0.0%	Shares	Sole	2025-02-14
2024-09-30	$3,099,960	654,000	0.0%	Shares	Sole	2024-11-14
2024-06-30	$3,073,800	654,000	0.0%	Shares	Sole	2024-08-20
2024-03-31	$2,975,700	654,000	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.